Bioptimus is building the first universal AI foundation model for biology designed to accelerate breakthrough discoveries and innovation in biomedicine. The company's mission is to create a reference foundation model of biology that will unlock AI capabilities for the biomedical ecosystem. A key initiative is the Spatial Tissue Embedding Learning Atlas (STELA), a multinational spatial data generation program in partnership with 10x Genomics and Broad Clinical Labs that aims to profile up to 100,000 patient specimens across three continents, integrating high-resolution spatial transcriptomics, histopathology imaging, and clinical records. With over $75M in funding and backed by leading international venture capitalists, Bioptimus combines world-class scientists and engineers to redefine the intersection of AI and life sciences.
Industry
AI/Machine Learning for Healthcare
Company Size
11-50 employees
Founded
2023
Remote Policy
Hybrid
Beta · Sourced from candidate reports
Be the first to share your experience with Bioptimus.
Your reply helps other candidates know what to expect.
